L’Oréal recalling acne creams sold at Walmart, Target, and Walgreens due to ‘cancer-causing chemical’
Makeup company L’Oréal has recalled popular brand La Roche-Posay’s acne cream because it may contain benzene, a cancer-causing chemical, according to New York Post. Effaclar Duo Dual-Action Acne Treatment contains benzoyl peroxide, which could have the known carcinogen, according to Valisure, an independent testing lab in Connecticut.
Cancer-causing chemical leads popular company to recall skin product
Benzene is a cancer-causing substance that is a colorless or light-yellow liquid used primarily as a solvent in the chemical and pharmaceutical industries, the National Cancer Institute said. NCI added that Benzene is a natural component of crude oil. Other natural sources include gas emissions from volcanoes and forest fires.
Popular makeup brand recalls acne treatment for possible cancer-causing ingredient
Makeup company L’Oréal S.A. has issued a recall on its popular acne cream Effaclar Duo due to concern that benzene, a known carcinogen, is in the product. Last year, independent Connecticut testing lab Valisure, flagged acne products with benzoyl peroxide, like L’Oréal’s, could contain benzene, reports the New York Post.
Acne treatments from brands such as Walgreens, La Roche-Posay, Proactiv are being recalled
Some popular acne creams are being recalled because the product may contain elevated levels of benzene, a chemical that causes cancer, the FDA said.
More popular acne products recalled due to cancer-causing chemical
A massive beauty company voluntarily recalled some of its skincare products due to the presence of a carcinogen. Now more products have been recalled due to the same reason. Health reported Wednesday how L’Oréal took their popular La Roche-Posay Effaclar Duo acne treatment due to a potential benzene contamination.
Acne product from popular skin care brand recalled due to potential cancer-causing chemical
The chemical that caused the recall is found in gasoline and tobacco; large amounts of the chemical can cause leukemia.
L’Oréal S.A. (OTCMKTS:LRLCY) Given Consensus Rating of “Hold” by Analysts
Shares of L’Oréal S.A. (OTCMKTS:LRLCY – Get Free Report) have received an average rating of “Hold” from the six brokerages ...
L’Oréal Act for Dermatology Aims to Democratize Skin Health Access
The 20 million euro, five-year program is to help support the 2.1 billion people worldwide living with skin disease.
Inside L'Oréal's Biggest Bet Yet on Innovation
The number of potential consumers in the U.S. is expected to increase by 12 million over the next five years, Nicolas ...
Meet world's five richest women: From L'Oréal to Amazon, which companies are they associated with?
They own billions of dollars but are also known for making strides in the fields of business and philanthropy. They are ...
Cosmetics Business3d
L’Oréal’s dermatology arm launches €20 million skin health programme
L’Oréal Groupe has launched L’Oréal Act for Dermatology, a five-year skin health programme, under its Dermatological Beauty ...
L’Oréal USA Sells Carol’s Daughter to Independent Entrepreneur
After a decade under its ownership, L’Oréal USA has sold Carol’s Daughter to an unnamed independent beauty entrepreneur. The ...
People8d
Bethenny Frankel's Secret to a 'Beach Glow' Is the $13 Illuminating Moisturizer I've Used for Years
Two of them are under-$20 picks available at Amazon, and one of her go-to products — the L’Oréal Paris True Match Lumi Glotion — has been a staple in my makeup bag for years. It’s even ...
Beauty Packaging2d
L’Oréal Reinforces Leadership and Commitment to Cosmetic Safety
Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our ...